Shares of M.D.C. Holdings, Inc. (NYSE:MDC) have received a consensus recommendation of “Hold” from the nine brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $33.83.
Several equities research analysts have commented on MDC shares. ValuEngine cut shares of M.D.C. from a “sell” rating to a “strong sell” rating in a research report on Friday, October 12th. Bank of America set a $34.00 price target on shares of M.D.C. and gave the stock a “buy” rating in a report on Thursday, October 11th. Wedbush cut their price target on shares of M.D.C. from $34.00 to $31.00 and set a “neutral” rating for the company in a report on Friday, November 2nd. JPMorgan Chase & Co. downgraded shares of M.D.C. from a “neutral” rating to an “underweight” rating and dropped their price objective for the company from $38.00 to $32.00 in a research note on Friday, September 21st. Finally, Zacks Investment Research cut shares of M.D.C. from a “hold” rating to a “sell” rating in a research report on Wednesday, October 17th.
NYSE MDC opened at $30.69 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 9.55 and a quick ratio of 2.45. The company has a market cap of $1.69 billion, a PE ratio of 11.90, a PEG ratio of 0.44 and a beta of 1.25. M.D.C. has a 1-year low of $25.14 and a 1-year high of $35.18.
M.D.C. (NYSE:MDC) last released its earnings results on Thursday, November 1st. The construction company reported $0.93 EPS for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.02). The business had revenue of $766.03 million for the quarter, compared to analyst estimates of $778.62 million. M.D.C. had a return on equity of 12.96% and a net margin of 6.21%. M.D.C.’s revenue was up 30.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.07 EPS. Equities analysts predict that M.D.C. will post 3.88 earnings per share for the current year.
A number of institutional investors have recently made changes to their positions in MDC. Schwab Charles Investment Management Inc. lifted its position in M.D.C. by 13.0% during the second quarter. Schwab Charles Investment Management Inc. now owns 388,631 shares of the construction company’s stock valued at $11,959,000 after purchasing an additional 44,769 shares during the last quarter. Swiss National Bank lifted its holdings in shares of M.D.C. by 6.5% in the 2nd quarter. Swiss National Bank now owns 78,169 shares of the construction company’s stock worth $2,405,000 after acquiring an additional 4,800 shares during the last quarter. GSA Capital Partners LLP lifted its holdings in shares of M.D.C. by 44.7% in the 2nd quarter. GSA Capital Partners LLP now owns 18,203 shares of the construction company’s stock worth $560,000 after acquiring an additional 5,625 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of M.D.C. by 5.0% in the 2nd quarter. BlackRock Inc. now owns 7,926,690 shares of the construction company’s stock worth $243,905,000 after acquiring an additional 378,947 shares during the last quarter. Finally, Legal & General Group Plc lifted its holdings in shares of M.D.C. by 5.7% in the 2nd quarter. Legal & General Group Plc now owns 99,556 shares of the construction company’s stock worth $3,039,000 after acquiring an additional 5,398 shares during the last quarter. Institutional investors and hedge funds own 78.62% of the company’s stock.
M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.
Featured Story: What is a good rate of return for a mutual fund?
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.